Clinical Trial Update: Mesalamine Pellet to Maintain Remission of Mild to Moderate Ulcerative Colitis [Phase 3]

View source ↗

Summary

Phase 3 trial update for mesalamine pellet to maintain remission in mild to moderate ulcerative colitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Ulcerative Colitis | Phase 3 | Status: COMPLETED